SeladelparSeladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

Sponsor:

Gilead Sciences

Code:

NCT06051617

Conditions

Primary Biliary Cholangitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Seladelpar

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-02. This information was provided to ClinicalTrials.gov by Gilead Sciences on 2026-08-11.